ICU

Designed for genetic testing in critically ill newborns and young children under 24 months in ICU. It covers multiple genetic conditions with overlapping symptoms and allows for a single test using dried blood spots for accurate diagnosis.

  • TAT : 28 working days
  • Sample : EDTA blood

Included Syndromes & Disorders

  • Alagille syndrome
  • Alpha-Thalassemia
  • Arginase deficiency
  • Beta-Thalassemia
  • Biotinidase deficiency
  • Biotin-thiamine-responsive basal ganglia disease
  • Carnitine deficiency
  • Congenital hypothyroidism
  • Cystic Fibrosis
  • Dystonia DOPA responsive
  • Factor VII deficiency
  • Glucose transporter 1 deficiency
  • Glutaric acidemia Type 1
  • Hereditary fructose intolerance
  • Holocarboxylase synthetase deficiency
  • Maple syrup urine disease (MSUD)
  • Non ketotic hyperglicinemia
  • Phenylketonuria
  • Pompe disease
  • Primary coenzyme Q10 deficiency
  • Pyridoxamine 5 phosphate oxidase deficiency
  • Pyridoxine-dependent epilepsy
  • Pyruvate carboxylase deficiency
  • Tuberous sclerosis complex
  • Tyrosinemia type I
  • VLCAD deficiency

IEM

For metabolic and liver diseases, screening for a diverse range of disorders including intermediary metabolism, energetic processes, and cellular organelle-related conditions.

  • TAT : 28 working days
  • Sample : EDTA blood

Included Syndromes & Disorders

  • Aicardi-Goutieres syndrome
  • Autoimmune lymphoproliferative syndrome
  • Ceroid lipofuscinosis
  • Congenital glycosylation disease
  • Familial hypercholesterolemia
  • Fatty acid oxidation disorder
  • Fatty liver disease
  • Glycogen storage disease
  • Hemophagocytic lymphohistiocytosis
  • Hereditary hemochromatosis
  • Hereditary spherocytosis
  • Leigh syndrome and mitochondrial encephalopathy
  • Leukodystrophy and peroxisome biogenesis disorders
  • Lipodystrophy syndromes
  • Lysosomal storage disease
  • Maple syrup urine disease
  • Methylmalonic acidemia
  • Mucopolysaccharidosis
  • Neurodegeneration with Brain Iron Accumulation
  • Non-ketotic hyperglycinemia
  • Organic acidemias
  • Porphyria
  • Refsum disease
  • Urea cycle disorder

Metabolic MOx

For patients suspected of metabolic disorders or complex conditions, especially in NICU/PICU settings. It offers fast results, utilises a multiomic approach, and includes enzyme activity testing and continuously updated biomarkers.

  • TAT : 28 working days
  • Sample : EDTA blood

Included Syndromes & Disorders

  • Congenital disorders of glycosylation and other disorders
    of protein modification
  • Defects in cholesterol and lipoprotein metabolism
  • Defects in hormone biogenesis or function
  • Disorder of phosphate, calcium and vitamin D metabolism
  • Disorders in the metabolism of purines, pyrimidines and nucleotides
  • Disorders in the metabolism of trace elements and metals
  • Disorders in the metabolism of vitamins and (non-protein) cofactors
  • Disorders of amino acid and peptide metabolism
  • Disorders of carbohydrate metabolism
  • Disorders of energy metabolism
  • Disorders of fatty acid and ketone body metabolism
  • Disorders of lipid and lipoprotein metabolism
  • Disorders of neurotransmitter metabolism
  • Disorders of porphyrin and heme metabolism
  • Disorders of the metabolism of sterols
  • Lysosomal disorders
  • Peroxisomal disorders
  • Porphyria and bilirubinemia

Mito comprehensive

Covers the entire mitochondrial genome and can detect heteroplasmy down to 15.0%. It also tests for nuclear genes related to mitochondrial diseases, which primarily affect organs with high energy demands.

  • TAT : 28 working days
  • Sample : EDTA blood

Included Syndromes & Disorders

  • Chronic progressive external ophthalmoplegia
  • Kearns-Sayre syndrome
  • Leigh’s syndrome and maternally inherited Leigh’s syndrome
  • Mitochondrial disorders
  • Mitochondrial encephalomyopathy, lactic acidosis and stroke-like
    episodes
  • Myoclonus epilepsy with ragged red fibers
  • Myogastrointestinal encephalomyopathy
  • NARP
  • Neonatal mitochondrial hepatopathies
  • Pearson syndrome

Mito Genome

Includes mitochondrial genes. Nuclear mitochondrial genes are not included.

  • TAT : 28 working days
  • Sample : EDTA blood

Included Syndromes & Disorders

  • Chronic progressive external ophthalmoplegia
  • Kearns-Sayre syndrome
  • Leber hereditary optic neuropathy
  • Leigh-like syndrome
  • Leigh syndrome
  • Mitochondrial disorders
  • NARP

Diabetes & obesity panel

Suitable for patients with various glucose metabolism abnormalities and insulin-related disorders, including Prader-Willi syndrome detection. However, it does not cover disorders caused by imprinting errors or uniparental disomy, except for the genomic region 15q11, which is included in the analysis.

  • TAT : 28 working days
  • Sample : EDTA blood

Included Syndromes & Disorders

  • Bardet-Biedl syndrome
  • Congenital glycosylation disease
  • Congenital hyperinsulinism
  • Congenital hypothyroidism
  • Diabetes insipidus
  • Growth hormone deficiency
  • Familial hypercholesterolemia
  • Hypoglycemia
  • Maturity onset diabetes of the young
  • Neonatal diabetes
  • Obesity
Upload Prescription
Book Home Visit